New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Elevance Health Inc.
ELV
Shape
US Flag

NYSE

114B

Medical - Healthcare Plans

Next Earning date - 16 Oct 2024

114B

Medical - Healthcare Plans

Next Earning date - 16 Oct 2024

492.07USD
Shape-6.18 ( -1.24%)
favorite-chart

Relative Strenght

51
favorite-chart

Volume Buzz

20%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

13%

Quote Panel

Shape
Updated October 7, 2024
1W -3.75 % 1M -9.22 % 3M -6.27 % 1Y 9.97 %

Key Metrics

Shape
  • Market Cap

    114.10B


  • Shares Outstanding

    231.89M


  • Share in Float

    230.92M


  • Dividende

    6.52


  • Earning Date

    16 Oct 2024


  • Price Target

    492.07


  • Average Volume

    1.01M


  • Beta

    0.828


  • Range

    435.99-567.26


  • Industry

    Medical - Healthcare Plans


  • Website

    https://www.elevancehealth.com


  • Sector

    Healthcare


Fundamentals

Shape

13.91x

P/E Ratio

0.66x

P/S Ratio

2.71x

P/B Ratio

0.7

Debt/Equity

3.9%

Net Margin

$28.5

EPS

How ELV compares to sector?

P/E Ratio

Relative Strength

Shape

ELV

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$184B

Shape321%

2025-Revenue

$39.38

Shape297%

2025-EPS

$10B

Shape23941%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Bank of America Securities

downgrade

Previous: Buy

2024-07-18

Now: Neutral

Morgan Stanley

upgrade

Previous: Not converted

2023-04-27

Now: Overweight

RBC Capital

upgrade

Previous: Not converted

2023-03-28

Now: Outperform

Bank of America Securities

upgrade

Previous: Not converted

2022-09-09

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+11%

7.53
vs 6.79

Q4.22

arrow
arrow

+2%

5.23
vs 5.14

Q1.23

arrow
arrow

+15%

9.46
vs 8.25

Q2.23

arrow
arrow

+12%

9.04
vs 8.04

Q3.23

arrow
arrow

+19%

8.99
vs 7.53

Q4.23

arrow
arrow

+7%

5.62
vs 5.23

Q1.24

arrow
arrow

+12%

10.64
vs 9.46

Q2.24

arrow
arrow

+12%

10.12
vs 9.04

Q3.24

arrow
arrow

+8%

9.69
vs 8.99

Q4.24

arrow
arrow

+21%

6.79
vs 5.62

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+11%

39.9B  vs 35.8B

Q4.22

arrow
arrow

+9%

39.9B  vs 36.6B

Q1.23

arrow
arrow

+11%

42.2B  vs 38.1B

Q2.23

arrow
arrow

+13%

43.7B  vs 38.6B

Q3.23

arrow
arrow

+7%

42.8B  vs 39.9B

Q4.23

arrow
arrow

+7%

42.6B  vs 39.9B

Q1.24

arrow
arrow

+1%

42.6B  vs 42.2B

Q2.24

arrow
arrow

0%

43.6B  vs 43.7B

Q3.24

arrow
arrow

+1%

43.5B  vs 42.8B

Q4.24

arrow
arrow

+3%

43.9B  vs 42.6B

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+4%

0.04
vs 0.05

Q4.22

arrow
arrow

+3%

0.03
vs 0.04

Q1.23

arrow
arrow

+5%

0.05
vs 0.03

Q2.23

arrow
arrow

+5%

0.05
vs 0.05

Q3.23

arrow
arrow

+3%

0.03
vs 0.05

Q4.23

arrow
arrow

+2%

0.02
vs 0.03

Q1.24

arrow
arrow

+6%

0.06
vs 0.02

Q2.24

arrow
arrow

+5%

0.05
vs 0.06

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

1473

1.5K
vs 1.5K

0%

Q4.22

arrow
arrow

1585

1.6K
vs 1.5K

8%

Q1.23

arrow
arrow

1533

1.5K
vs 1.6K

-3%

Q2.23

arrow
arrow

1544

1.5K
vs 1.5K

1%

Q3.23

arrow
arrow

1555

1.6K
vs 1.5K

1%

Q4.23

arrow
arrow

1687

1.7K
vs 1.6K

8%

Q1.24

arrow
arrow

1700

1.7K
vs 1.7K

1%

Q2.24

arrow
arrow

1707

1.7K
vs 1.7K

0%

Earnings Growth

Latest News